Wissenschaftliche Arbeiten

Prof. Dr. Gülden Eser Karlıdağ

80 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Postexposure prophylaxis for HIV among healthcare workers in Türkiye: a descriptive, multicenter retrospective study

    Turkish journal of medical sciences, 2026

    DOI 10.55730/1300-0144.6186 PMID 42058987 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  2. Beyond viral suppression: determinants of health-related quality of life in a national HIV cohort in Turkiye

    AIDS Care, 2026

    DOI 10.1080/09540121.2026.2697987 PMID 42492089 Quelle: ORCID

  3. Comparison of the Clinical Frailty Scale and the FRAIL Scale for predicting short-term outcomes in older adults hospitalized with infectious diseases: a multicentre prospective study

    BMC Geriatrics, 2026

    DOI 10.1186/s12877-026-08634-w Frei zugänglicher VolltextQuelle: OpenAlex

  4. Stenotrophomonas maltophilia infections in intensive care units: a prospective and international ID-IRI study

    The Journal of Infection in Developing Countries, 2026

    DOI 10.3855/jidc.22056 PMID 41990058 Frei zugänglicher VolltextQuelle: ORCID

  5. Follow-up, diagnosis, and outcomes of fever of unknown origin cases in whom no diagnosis was established after initial evaluation: an ID-IRI (Infectious Diseases - International Research Initiative) observational retrospective cohort study

    BMC Infectious Diseases, 2026

    DOI 10.1186/s12879-026-13431-2 PMID 42115988 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  6. Risk factors and vaccination gaps for herpes zoster in people living with HIV: A multicenter multivariable study

    International Journal of STD & AIDS, 2026

    DOI 10.1177/09564624261436935 PMID 41873695 Frei zugänglicher VolltextQuelle: OpenAlex

  7. Community acquired bacteremia in older adults: International and prospective infectious diseases-international research initiative (ID-IRI) study

    International Journal of Infectious Diseases, 2026

    DOI 10.1016/j.ijid.2026.108767 PMID 42107874 Frei zugänglicher VolltextQuelle: OpenAlex

  8. Survival in Immunocompromised Adults with Pneumocystis jirovecii Pneumonia: A Multicenter ID-IRI Study

    Mycopathologia, 2026

    DOI 10.1007/s11046-026-01099-w PMID 42742836 Quelle: OpenAlex

  9. Diagnosis and outcomes of fever of unknown origin cases with an erythrocyte sedimentation rate of 100 mm/h or more: An International ID-IRI (Infectious Diseases – International Research Initiative) Observational Retrospective Cohort Study

    Medicine, 2025

    DOI 10.1097/md.0000000000043341 PMID 40696644 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  10. Epidemiology of ventilator associated events in intubated patients: a multicenter observational study

    BMC Infectious Diseases, 2025

    DOI 10.1186/s12879-025-11341-3 PMID 41121004 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  11. The Use of Serum Scoring Systems in Predicting Liver Fibrosis Caused by Chronic Hepatitis B: A Retrospective Case-Control Study

    Medicina, 2025

    DOI 10.3390/medicina61081490 PMID 40870535 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  12. An Intensive Care Outbreak Caused by Burkholderia cepacia from Bacterial Filters

    Pathogens, 2025

    DOI 10.3390/pathogens14030266 PMID 40137751 Frei zugänglicher VolltextQuelle: ORCID

  13. Clinical and inflammatory predictors of outpatient treatment failure in uncomplicated skin and soft tissue infections: a prospective multicenter study from Türkiye

    BMC Infectious Diseases, 2025

    DOI 10.1186/s12879-025-12167-9 PMID 41455920 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  14. Factors affecting inflammatory markers in neutropenic patients with bacteremia: An international ID-IRI study

    Microbes and Infectious Diseases /Microbes and Infectious Diseases, 2025

    DOI 10.21608/mid.2025.438319.3402 Frei zugänglicher VolltextQuelle: OpenAlex

  15. Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study

    Medical mycology, 2024

    DOI 10.1093/mmy/myae064 PMID 38914466 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  16. Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study

    International Journal of Infectious Diseases, 2024

    DOI 10.1016/j.ijid.2024.107228 PMID 39216784 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  17. Ventilator-associated event (VAE) epidemiology and prognosis: Preliminary results of VAE-Türkiye

    Journal of Critical Care, 2024

    DOI 10.1016/j.jcrc.2024.154671 1 Zitation (OpenAlex) Quelle: OpenAlex

  18. The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-55886-w PMID 38433274 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  19. Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study

    European Journal of Clinical Microbiology & Infectious Diseases, 2023

    DOI 10.1007/s10096-023-04630-9 PMID 37318601 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  20. Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study

    Turkish Journal of Medical Sciences, 2023

    DOI 10.55730/1300-0144.5641 PMID 37476892 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  21. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study

    European Journal of Clinical Microbiology and Infectious Diseases, 2023

    DOI 10.1007/s10096-023-04561-5 PMID 36790531 30 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  22. EKMUD HIV ÇALIŞMA GRUBU KOHORT VERİLERİ

    AYBU AVESIS, 2023

    Quelle: OpenAlex

  23. Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)—based survey

    Antimicrobial Resistance and Infection Control, 2023

    DOI 10.1186/s13756-023-01208-0 PMID 36782267 54 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  24. Features of Mpox infection: The analysis of the data submitted to the ID-IRI network

    New Microbes and New Infections, 2023

    DOI 10.1016/j.nmni.2023.101154 PMID 37260588 9 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  25. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study

    International Journal of Antimicrobial Agents, 2023

    DOI 10.1016/j.ijantimicag.2023.106919 PMID 37423582 14 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  26. Vaccine hesitancy and refusal among parents: An international ID-IRI survey

    Journal of Infection in Developing Countries, 2022

    DOI 10.3855/jidc.16085 PMID 35797304 18 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  27. Antibiotic use and Influencing Factors Among Hospitalized Patients with COVID-19: A Multicenter Point-Prevalence Study from Turkey

    Balkan medical journal, 2022

    DOI 10.4274/balkanmedj.galenos.2022.2021-11-62 PMID 35611705 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  28. Can laboratory parameters be an alternative to CT and RT‐PCR in the diagnosis of COVID ‐19? A machine learning approach

    International Journal of Imaging Systems and Technology, 2022

    DOI 10.1002/ima.22705 PMID 35465212 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  29. The Effect of Comorbidities on the Prognosis of COVID-19 is More Than Thought: A Summary of Our Region

    DSpace - FIRAT (Fırat University), 2022

    Frei zugänglicher VolltextQuelle: OpenAlex

  30. COVID-19 Pandemi Süreci Ani Sensörinöral İşitme Kaybı İnsidansını Etkiledi Mi?

    DSpace - FIRAT (Fırat University), 2022

    Frei zugänglicher VolltextQuelle: OpenAlex

  31. Clinical findings in patients with leprosy who are infected with COVID-19: a case series from Elazıg, Turkey

    Leprosy Review, 2021

    DOI 10.47276/lr.92.2.134 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  32. Evaluation of the effect of COVID-19 disease on ventricular density using computer tomography

    The Annals of Clinical and Analytical Medicine, 2021

    DOI 10.4328/acam.20381 Frei zugänglicher VolltextQuelle: OpenAlex

  33. Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis?

    Biotechnic & Histochemistry, 2020

    DOI 10.1080/10520295.2020.1714732 PMID 32011178 10 Zitationen (Europe PMC) Quelle: ORCID

  34. Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis?

    Biotechnic & Histochemistry, 2020

    Quelle: ORCID

  35. Effect of Infection on Mental Health in COVID-19 Positive Cases and its Relationship with Clinical Variables

    Health, 2020

    DOI 10.5152/pcp.2021.20165 PMID 39619344 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  36. Kronik Hepatit B Hastalarında Karaciğer HistolojisiniÖngörmede Noninvaziv Biyokimyasal BelirteçlerinDeğerlendirilmesi

    Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, 2020

    Quelle: OpenAlex

  37. Does Liver Density Change in Computed Tomography in COVID-19 Patients?

    Annals of Medical Research, 2020

    DOI 10.2139/ssrn.3720776 Frei zugänglicher VolltextQuelle: OpenAlex

  38. Antibiotic Consumption, Resistance Data, and Prevention Strategies

    Mediterranean Journal of Infection Microbes and Antimicrobials, 2019

    DOI 10.4274/mjima.2018.35 10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  39. Hepatitis and HIV Seropositivity among Healthcare Workers at Elazığ Oral and Dental Healthcare Center

    Viral Hepatitis Journal, 2019

    DOI 10.4274/vhd.galenos.2019.2019.0014 Frei zugänglicher VolltextQuelle: ORCID

  40. Viral Hepatitis Prevalence in Two Cognitively Different Risk Groups

    Viral Hepatitis Journal, 2019

    DOI 10.4274/vhd.galenos.2019.2019.0018 Frei zugänglicher VolltextQuelle: ORCID

  41. Hepatitis and HIV Seropositivity among Healthcare Workers at Elazığ Oral and Dental Healthcare Center

    2019

    Quelle: ORCID

  42. Kronik Hepatit B Hastalarında Hepatit Delta Sıklığı.

    Klimik Journal/Klimik Dergisi, 2019

    Quelle: ORCID

  43. Prevalence of Hepatitis Delta in Chronic Hepatitis B Patients/Kronik Hepatit B Hastalarinda Hepatit Delta Sikligi.

    KLIMIK Journal, 2019

    Quelle: ORCID

  44. The relationship between duration, stage and, treatment of illness and depression or anxiety in chronic hepatitis B patients

    Anatolian Journal of Psychiatry, 2019

    DOI 10.5455/apd.27821 Frei zugänglicher VolltextQuelle: ORCID

  45. The relationship between duration, stage and, treatment of illness and depression or anxiety in patients with chronic hepatitis B.

    Anatolian Journal of Psychiatry/Anadolu Psikiyatri Dergisi, 2019

    Quelle: ORCID

  46. Viral Hepatitis Prevalence in Two Cognitively Different Risk Groups

    2019

    Quelle: ORCID

  47. The Mortality Rate and Related Factors in Patients with Community-Acquired Pneumonia Requiring Hospitalization

    Turkish Thoracic Journal, 2019

    DOI 10.5152/turkthoracj.2019.202 Frei zugänglicher VolltextQuelle: OpenAlex

  48. HBsAg, Anti-HBs, Anti-HCV and HIV Seroprevalence in Hemodialysis Patients in Elazığ Province

    Viral Hepatitis Journal, 2018

    DOI 10.4274/vhd.2018.0004 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  49. Antibiyotik tüketimi, direnç verileri ve önlem stratejileri

    2018

    Quelle: ORCID

  50. HBsAg, Anti-HBs, Anti-HCV and HIV Seroprevalence in Hemodialysis Patients in Elazığ Province

    2018

    Quelle: ORCID